106 related articles for article (PubMed ID: 8438618)
21. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
Barry EM; Wang J; Wu T; Davis T; Levine MM
Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
[TBL] [Abstract][Full Text] [Related]
23. A phase I trial of WRSS1, a
Raqib R; Sarker P; Zaman K; Alam NH; Wierzba TF; Maier N; Talukder K; Baqui AH; Suvarnapunya AE; Qadri F; Walker RI; Fix A; Venkatesan MM
Hum Vaccin Immunother; 2019; 15(6):1326-1337. PubMed ID: 30794051
[No Abstract] [Full Text] [Related]
24. Oral administration of live Shigella vaccine candidates in rhesus monkeys show no evidence of competition for colonization and immunogenicity between different serotypes.
Ranallo RT; Kaminski R; Baqar S; Dutta M; Lugo-Roman LA; Boren T; Barnoy S; Venkatesan MM
Vaccine; 2014 Mar; 32(15):1754-60. PubMed ID: 24522159
[TBL] [Abstract][Full Text] [Related]
25. Construction of aromatic dependent Shigella flexneri 2a live vaccine candidate strains: deletion mutations in the aroA and the aroD genes.
Verma NK; Lindberg AA
Vaccine; 1991 Jan; 9(1):6-9. PubMed ID: 2008803
[TBL] [Abstract][Full Text] [Related]
26. [Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
Belaia IuA; Gekker VD; Kuz'min SN; Sergeeva NS
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):63-9. PubMed ID: 4216253
[No Abstract] [Full Text] [Related]
27. [Enteric dysentery vaccines and their effectiveness in a rabbit intestinal loop model. I. The residual virulence of attenuated vaccinal strains of Shigella administered into the intestinal loops].
Polotskiĭ IuE; Fedotova IuM; Rukhamina ML; Seliverstova VG
Zh Mikrobiol Epidemiol Immunobiol; 1980 Nov; (11):32-6. PubMed ID: 7004003
[TBL] [Abstract][Full Text] [Related]
28. Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers.
Kärnell A; Li A; Zhao CR; Karlsson K; Nguyen BM; Lindberg AA
Vaccine; 1995 Jan; 13(1):88-99. PubMed ID: 7762285
[TBL] [Abstract][Full Text] [Related]
29. Construction of a stable attenuated Shigella sonnei DeltavirG vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model.
Hartman AB; Venkatesan MM
Infect Immun; 1998 Sep; 66(9):4572-6. PubMed ID: 9712824
[TBL] [Abstract][Full Text] [Related]
30. Shigellosis in custodial institutions. 3. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated shigella vaccines.
Levine MM; Gangarosa EJ; Werner M; Morris GK
J Pediatr; 1974 Jun; 84(6):803-6. PubMed ID: 4596999
[No Abstract] [Full Text] [Related]
31. Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes.
Kärnell A; Sweiha H; Lindberg AA
Vaccine; 1992; 10(3):167-74. PubMed ID: 1557932
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.
DeLaine BC; Wu T; Grassel CL; Shimanovich A; Pasetti MF; Levine MM; Barry EM
Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27106253
[TBL] [Abstract][Full Text] [Related]
33. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.
Mel D; Gangarosa EJ; Radovanovic ML; Arsic BL; Litvinjenko S
Bull World Health Organ; 1971; 45(4):457-64. PubMed ID: 4948417
[TBL] [Abstract][Full Text] [Related]
34. [Liver and kidney function after immunization with an enteral vaccine from Shigella flexneri and Shigella sonnei antigens (blood biochemical test data)].
Kreĭnin LS; Sergeev VV; Matchin VG; Domnikova AA; Elkina SI
Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):67-9. PubMed ID: 7034416
[No Abstract] [Full Text] [Related]
35. Construction and evaluation of a virG thyA double mutant of Shigella flexneri 2a as a candidate live-attenuated oral vaccine.
Yoshikawa M; Sasakawa C; Okada N; Takasaka M; Nakayama M; Yoshikawa Y; Kohno A; Danbara H; Nariuchi H; Shimada H
Vaccine; 1995; 13(15):1436-40. PubMed ID: 8578822
[TBL] [Abstract][Full Text] [Related]
36. Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in volunteers.
Li A; Pál T; Forsum U; Lindberg AA
Vaccine; 1992; 10(6):395-404. PubMed ID: 1598788
[TBL] [Abstract][Full Text] [Related]
37. Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine.
Noriega FR; Losonsky G; Lauderbaugh C; Liao FM; Wang JY; Levine MM
Infect Immun; 1996 Aug; 64(8):3055-61. PubMed ID: 8757833
[TBL] [Abstract][Full Text] [Related]
38. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
[No Abstract] [Full Text] [Related]
39. [Construction and characterization of a live attenuated Shigella flexneri 2a vaccine strain, sf301 Delta virG and dsbA33G].
Yang XF; Zhou L; Zheng J; Si LS; Wang YL
Wei Sheng Wu Xue Bao; 2005 Oct; 45(5):748-52. PubMed ID: 16342769
[TBL] [Abstract][Full Text] [Related]
40. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
